The effects of sub-chronic administration of hydrocortisone on hormonal and psychological responses to L-tryptophan in normal male volunteers

Psychopharmacology (Berl). 2002 Aug;163(1):68-75. doi: 10.1007/s00213-002-1094-2. Epub 2002 Jul 10.

Abstract

Rationale: 5-Hydroxytryptamine(1A) (5-HT(1A)) receptor function has been shown to be attenuated by corticosteroid hormones in a variety of animal experimental paradigms. It has been suggested that this effect may be central to the pathophysiology of severe depressive illness in humans, a condition in which 5-HT(1A) receptor function is reduced and corticosteroid hormone levels are elevated. Evidence suggests that the hormonal response to L-tryptophan ( L-TRP) is mediated by 5-HT(1A) receptors. This response has been shown to be reduced following acute administration of hydrocortisone, and we hypothesised that sub-chronic administration of hydrocortisone would also blunt it.

Objectives: To examine the effects of sub-chronic administration of hydrocortisone on hormonal and psychological responses to L-TRP infusion in healthy male subjects. To ascertain whether cortisol was exerting effects on prolactin release directly at the pituitary rather than via hypothalamic 5-HT(1A) receptors, a thyroid-releasing hormone (TRH) challenge test was performed.

Methods: Fourteen healthy male volunteers took part in a random-order, double-blind, placebo-controlled study, in which 20 mg hydrocortisone or placebo was administered twice daily for 7 days before infusion of L-TRP. A TRH challenge was administered to eight of the subjects following the L-TRP infusion.

Results: Pre-treatment with hydrocortisone significantly reduced the growth hormone (GH) and cortisol responses, but not the prolactin (PRL) response to the infusion. TRH administration caused a robust increase in PRL, but this response was not attenuated by hydrocortisone pre-treatment. The TSH response to TRH was blunted. There was no effect of pre-treatment on psychological responses to L-TRP.

Conclusions: The attenuation in GH response following hydrocortisone pre-treatment could indicate a reduction in 5-HT(1A) receptor function, although it is probable that it is attributable to the action of hydrocortisone at the pituitary level. More precise, non-neuroendocrine models of 5-HT(1A) receptor function are necessary to clarify this.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / pharmacology*
  • Hormones / blood*
  • Human Growth Hormone / metabolism
  • Humans
  • Hydrocortisone / blood
  • Hydrocortisone / pharmacology*
  • Infusions, Intravenous
  • Male
  • Pituitary Gland / drug effects
  • Pituitary Gland / physiology
  • Prolactin / metabolism
  • Receptors, Serotonin / drug effects
  • Receptors, Serotonin, 5-HT1
  • Thyrotropin-Releasing Hormone / pharmacology
  • Tryptophan / pharmacology*

Substances

  • Anti-Inflammatory Agents
  • Hormones
  • Receptors, Serotonin
  • Receptors, Serotonin, 5-HT1
  • Human Growth Hormone
  • Thyrotropin-Releasing Hormone
  • Tryptophan
  • Prolactin
  • Hydrocortisone